Gold Silver Reports (GSR) – Galaxy Surfactants Falls Below Issue Price After U.S. FDA Issues Form 483 — The Mumbai-based specialty chemical maker fell as much as 4.2 percent to Rs 1,429 after it received 13 observations from the U.S. drug regulator for two products — Octyl Methoxy Cinnamate and Octocylene manufactured from its facility at Tarapur in Maharashtra and Jhagadia in Gujarat, the company said in an exchange filing.
Read More: RPG Life Sciences Rallies After Large Block Deal
All the observations are procedural in nature and it will be replying to the U.S. FDA within the stipulated time, the exchange filing added.
